CXCR6 Promotes Atherosclerosis by Supporting T-cell Homing, Interferon-gamma Production, and Macrophage Accumulation in the Aortic Wall
Overview
Authors
Affiliations
Background: T lymphocytes are thought to be important in atherosclerosis, but very little is known about the mechanisms of lymphocyte recruitment into atherosclerosis-prone aortas. In this study we tested the hypothesis that CXCR6, a chemokine receptor that is expressed on a subset of CD4+ T helper 1 cells and natural killer T cells, is involved in lymphocyte homing into the aortic wall and modulates the development and progression of atherosclerosis.
Methods And Results: To investigate the role of CXCR6 in the development and progression of atherosclerosis, we bred CXCR6-deficient (CXCR6(GFP/GFP)) mice with apolipoprotein E-deficient (ApoE(-/-)) mice. We found that CXCR6(GFP/GFP)/ApoE(-/-) mice fed a Western diet for 17 weeks or a chow diet for 56 weeks had decreased atherosclerosis compared with ApoE(-/-) controls. Flow cytometry analysis of the aortas from CXCR6(GFP/GFP)/ApoE(-/-) mice showed that the reduction of atherosclerosis was accompanied by a decreased percentage of CXCR6+ T cells within the aortas. Short-term homing experiments demonstrated that CXCR6 is involved in the recruitment of CXCR6+ leukocytes into the atherosclerosis-prone aortic wall. The reduced percentage of CXCR6+ T cells within the aortas resulted in significantly diminished production of interferon-gamma and reduction of CD11b+/CD68+ macrophages in the aorta.
Conclusions: These data provide evidence for a proatherosclerotic role of CXCR6. Absence of CXCR6 alters the recruitment of CXCR6+ leukocytes and modulates the local immune response within the aortic wall.
Immunological perspectives on atherosclerotic plaque formation and progression.
Pi H, Wang G, Wang Y, Zhang M, He Q, Zheng X Front Immunol. 2024; 15:1437821.
PMID: 39399488 PMC: 11466832. DOI: 10.3389/fimmu.2024.1437821.
The role of immune cells in different stages of atherosclerosis.
He C, Kim H, Park J, Guo J, Huang W Int J Med Sci. 2024; 21(6):1129-1143.
PMID: 38774746 PMC: 11103388. DOI: 10.7150/ijms.94570.
Targeting immune cell recruitment in atherosclerosis.
Doring Y, van der Vorst E, Weber C Nat Rev Cardiol. 2024; 21(11):824-840.
PMID: 38664575 DOI: 10.1038/s41569-024-01023-z.
Breaking tolerance: the autoimmune aspect of atherosclerosis.
Khan A, Roy P, Ley K Nat Rev Immunol. 2024; 24(9):670-679.
PMID: 38472321 PMC: 11682649. DOI: 10.1038/s41577-024-01010-y.
ILC2-mediated immune crosstalk in chronic (vascular) inflammation.
Kral M, van der Vorst E, Surnov A, Weber C, Doring Y Front Immunol. 2024; 14:1326440.
PMID: 38179045 PMC: 10765502. DOI: 10.3389/fimmu.2023.1326440.